نتائج البحث

Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.

• Authors : Haisley, K. R.¹; Hart, K. D.¹; Nabavizadeh, N.²

• Source: Diseases of the Esophagus. Jul2017, Vol. 30 Issue 7, p1-7. 7p.

تفاصيل العنوان

Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real‐world analysis.

• Authors : Zhang, Yao; Li, Huiting; Yu, Bo

Subjects: THERAPEUTIC use of antineoplastic agents; SQUAMOUS cell carcinoma; MEDICAL information storage & retrieval systemsCHINA

• Source: Thoracic Cancer; May2024, Vol. 15 Issue 13, p1072-1081, 10p

تفاصيل العنوان

Neoadjuvant Chemotherapy in Patients with HER2- Negative Breast Cancer: A Report from Clinical Breast Cancer Registry of Iran.

• Authors : Roudini, Kamran¹; Mirzania, Mehrzad¹; Yavari, Tahereh²

• Source: Archives of Iranian Medicine (AIM). Apr2024, Vol. 27 Issue 4, p206-215. 10p.

تفاصيل العنوان

Additive value of diffusion‐weighted MRI in the I‐SPY 2 TRIAL

• Authors : Li, Wen; Newitt, David C; Wilmes, Lisa J

Subjects: Biomedical and Clinical Sciences; Clinical Sciences; Oncology and Carcinogenesis

• Source: Journal of Magnetic Resonance Imaging. 50(6)

تفاصيل العنوان

Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy

• Authors : Jipping, Kristien M.; Hulshoff, Jan Binne; van Amerongen, Evita A.

Subjects: CROSS vs Cis; 5FU; distribution recurrent disease

• Source: Jipping , K M , Hulshoff , J B , van Amerongen , E A , Bright , T I , Watson , D I & Plukker , J T M 2017 , ' Influence of tumor response and treatment schedule on the

تفاصيل العنوان

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

• Source: Randomized Phase III Trial of Paclitaxel +Trastuzumab + Lapatinib Versus Paclitaxel + Trastuzumab as Neoadjuvant Treatment of

تفاصيل العنوان

Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling

• Authors : Janine M. Mahoney; Frankie A. Holmes; Yasir Nagarwala

Subjects: Receptor, ErbB-2; medicine.medical_treatment; Biomarkers, Pharmacological

• Source: BMC Research Notes

تفاصيل العنوان

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

• Authors : Tindara Franchina; Silvia Schifano; Vincenzo Adamo

Subjects: 0301 basic medicine; Oncology; medicine.medical_specialty

• Source: OncoTargets and therapy

تفاصيل العنوان

Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy

• Authors : Hong Zhang; V. Valero; Gabriel N. Hortobagyi

Subjects: Oncology; Cancer Research; Receptor, ErbB-2

• Source: British Journal of Cancer

تفاصيل العنوان

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

• Authors : AstraZeneca; Celgene

• Source: Multimodality Therapy With Induction Carboplatin/Nab-Paclitaxel/Durvalumab Followed by Surgical Resection and Risk-adapted Adjuvant Therapy for the Treatment of

تفاصيل العنوان